California Health Watch
SEE OTHER BRANDS

Your best source on health and wellness news from California

California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on June 20, 2025

Qalitex Urges Brands to Address Moisture Sensitivity Risks in Powdered Supplement Stability

Qalitex Urges Brands to Address Moisture Sensitivity Risks in Powdered Supplement Stability

Qalitex advises brands to address moisture risks in powdered supplements, warning that humidity exposure can undermine shelf-life and microbial stability. IRVINE, CA, UNITED STATES, June 20, 2025 /⁨EINPresswire.com⁩/ -- Qalitex Laboratories, a provider of …

Oceans Luxury Rehab Unveils Exclusive Oceanfront Alcohol Recovery Program in Orange County

Oceans Luxury Rehab Unveils Exclusive Oceanfront Alcohol Recovery Program in Orange County

Oceans Luxury Rehab Unveils Exclusive Oceanfront Alcohol Recovery Program in Orange County ORANGE COUNTY, CA, UNITED STATES, June 20, 2025 /⁨EINPresswire.com⁩/ -- Oceans Luxury Rehab, a premier addiction treatment provider in Southern California, today …

Qalitex Highlights Importance of Real-Time Stability Testing in Post-Market Surveillance

Qalitex Highlights Importance of Real-Time Stability Testing in Post-Market Surveillance

Qalitex urges brands to use real-time stability data in post-market checks, warning accelerated studies alone may not reflect true shelf-life. IRVINE, CA, UNITED STATES, June 20, 2025 /⁨EINPresswire.com⁩/ -- Qalitex Laboratories, a provider of scientific …

AmeXio Group Expands U.S. Market Presence, Prioritizing Medical Device Sector in Strategic Growth Plan

AmeXio Group Expands U.S. Market Presence, Prioritizing Medical Device Sector in Strategic Growth Plan

SAN JOSE, CA, UNITED STATES, June 20, 2025 /⁨EINPresswire.com⁩/ -- AmeXio Group, a global leader in structured content management (SCM) and enterprise content management (ECM) solutions, is expanding its reach within the U.S. market to meet the evolving …

Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671

Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671

SAN FRANCISCO, June 20, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, today announced two upcoming late- …

Inozyme Pharma, Inc. Announces Postponement of 2025 Annual Meeting of Stockholders

Inozyme Pharma, Inc. Announces Postponement of 2025 Annual Meeting of Stockholders

BOSTON, June 20, 2025 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) today announced that it has postponed its 2025 Annual Meeting of Stockholders (the “Annual Meeting”), which was scheduled to be held on June 25, 2025, in light of the previously …

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NOVATO, Calif., June 20, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of …

Cyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred Stock

Cyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred Stock

KUALA LUMPUR, June 20, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (“Cyclacel”) (NASDAQ: CYCC, NASDAQ: CYCCP), a biopharmaceutical company that develops innovative cancer medicine, today announced that it has entered into a securities purchase …

The Ensign Group, Inc. Announces Retirement of Its Executive Chairman

The Ensign Group, Inc. Announces Retirement of Its Executive Chairman

SAN JUAN CAPISTRANO, Calif., June 20, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG or “Ensign”), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, …

AIM ImmunoTech Announces NYSE American Notice of Noncompliance With Minimum Stockholders’ Equity Requirements

AIM ImmunoTech Announces NYSE American Notice of Noncompliance With Minimum Stockholders’ Equity Requirements

NYSE American previously issued similar warning for same matter and issued the new notice because the deficiency remains as of March 31, 2025 AIM has until June 11, 2026 to regain compliance OCALA, Fla., June 20, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc …

Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass., June 20, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of therapies for …

ArriVent Announces Investor Event on Firmonertinib Path Forward for EGFR PACC Mutant NSCLC

ArriVent Announces Investor Event on Firmonertinib Path Forward for EGFR PACC Mutant NSCLC

NEWTOWN SQUARE, Pa., June 20, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced …

Larimar Therapeutics Announces Regulatory Update Call on the Nomlabofusp Program for the Treatment of Friedreich’s Ataxia

Larimar Therapeutics Announces Regulatory Update Call on the Nomlabofusp Program for the Treatment of Friedreich’s Ataxia

BALA CYNWYD, Pa., June 20, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that the Company will host a …

Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007’s Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions

Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007’s Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions

Presentation to highlight WVE-007 (INHBE GalNAc-siRNA) as a potential novel and unique obesity treatment leading to healthy weight loss and supporting preclinical data demonstrating potent and durable reduction in Activin E resulting in fat loss with …

PharmAla Files Preliminary Base Shelf Prospectus

PharmAla Files Preliminary Base Shelf Prospectus

TORONTO, June 20, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its …

Shuttle Pharmaceuticals Announces Pricing of $4.25 Million Private Placement Priced At-the-Market

Shuttle Pharmaceuticals Announces Pricing of $4.25 Million Private Placement Priced At-the-Market

GAITHERSBURG, Md., June 20, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …

Lipella Pharmaceuticals Announces Delisting from Nasdaq Capital Market

Lipella Pharmaceuticals Announces Delisting from Nasdaq Capital Market

PITTSBURGH, June 20, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (OTC: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for diseases with significant unmet needs, today announced that the …

Three California Dispensaries Help Redefine Cannabis Retail Across Los Angeles and San Francisco

Three California Dispensaries Help Redefine Cannabis Retail Across Los Angeles and San Francisco

The Cure Company, Sensi Retail, and San Pancho Cannabis Club Introduce New Models of Design, Access, and Community in a Shifting Market LOS ANGELES, CA, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- As California’s cannabis industry matures, a …

Qalitex Examines Impact of Supply Chain Variability on Stability Outcomes

Qalitex Examines Impact of Supply Chain Variability on Stability Outcomes

Qalitex warns that global supply chain variability may compromise product stability; urges brands to reassess shelf-life data when sourcing or logistics change. IRVINE, CA, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- Qalitex Laboratories, a …

SlimJaro Advanced Weight Loss Supplement in 2025: Can Targeting Inflammation Extra Body Fat, Read Slim Jaro Benefits & Side Effects

SlimJaro Advanced Weight Loss Supplement in 2025: Can Targeting Inflammation Extra Body Fat, Read Slim Jaro Benefits & Side Effects

New York City, NY, June 20, 2025 (GLOBE NEWSWIRE) -- In 2025, weight loss has become more complicated than simply cutting calories or hitting the gym. Many people around the world are following standard health advice yet still struggle with slow or …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service